Cargando…

Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction

BACKGROUND: Cardiovascular diseases and type 2 diabetes mellitus (T2DM) may have common developmental mechanisms associated with lipid metabolism disorders. Dyslipidemia and progression of atherosclerosis in people with T2DM are accompanied by an increase in cardiovascular mortality. This study exam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruzdeva, Olga, Uchasova, Evgenya, Dyleva, Yulia, Akbasheva, Olga, Karetnikova, Victoria, Shilov, Aleksandr, Barbarash, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722009/ https://www.ncbi.nlm.nih.gov/pubmed/29255368 http://dx.doi.org/10.2147/DMSO.S149463

Ejemplares similares

Early Effects of Treatment Low-Dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction
por: Gruzdeva, Olga, et al.
Publicado: (2016)

Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction
por: Barbarash, Olga, et al.
Publicado: (2016)

Biological markers and cardiac remodelling following the myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2019)

Dose-dependent effects of atorvastatin on myocardial infarction
por: Barbarash, Olga, et al.
Publicado: (2015)

The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction
por: Barbarash, Olga, et al.
Publicado: (2016)

Relationship key factor of inflammation and the development of complications in the late period of myocardial infarction in patients with visceral obesity
por: Gruzdeva, Olga, et al.
Publicado: (2017)

Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2014)

Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study
por: Barbarash, Olga, et al.
Publicado: (2017)

Relationships between epicardial adipose tissue thickness and adipo-fibrokine indicator profiles post-myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2018)

Insulin resistance and inflammation markers in myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2013)

Relationship between epicardial and perivascular fatty tissue and adipokine-cytokine level in coronary artery disease patients
por: Gruzdeva, Olga, et al.
Publicado: (2019)

Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance
por: Gruzdeva, Olga, et al.
Publicado: (2014)

Glucose levels as a prognostic marker in patients with ST-segment elevation myocardial infarction: a case–control study
por: Karetnikova, Victoria, et al.
Publicado: (2016)

Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2013)

Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure
por: Gruzdeva, Olga, et al.
Publicado: (2013)

Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction
por: Belenkova, Yulia, et al.
Publicado: (2015)

Use of thrombin generation test for monitoring hemostasis in coronary bypass surgery
por: Gruzdeva, Olga, et al.
Publicado: (2017)

Localization of fat depots and cardiovascular risk
por: Gruzdeva, Olga, et al.
Publicado: (2018)

Leptin resistance: underlying mechanisms and diagnosis
por: Gruzdeva, Olga, et al.
Publicado: (2019)

Serum neutrophil gelatinase-associated lipocalin the estimation of hospital prognosis in patients with ST-elevated myocardial infarction
por: Karetnikova, Victoria, et al.
Publicado: (2017)

Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction
por: Karetnikova, Victoria, et al.
Publicado: (2016)

Adipocytes Directly Affect Coronary Artery Disease Pathogenesis via Induction of Adipokine and Cytokine Imbalances
por: Gruzdeva, Olga, et al.
Publicado: (2019)

Prognostic potential of cardiac structural and functional parameters and N-terminal propeptide of type III procollagen in predicting cardiac fibrosis one year after myocardial infarction with preserved left ventricular ejection fraction
por: Osokina, Anastasia, et al.
Publicado: (2021)

Serum and Echocardiographic Markers May Synergistically Predict Adverse Cardiac Remodeling after ST-Segment Elevation Myocardial Infarction in Patients with Preserved Ejection Fraction
por: Pecherina, Tamara, et al.
Publicado: (2020)

Impact of recipient-related factors on structural dysfunction of xenoaortic bioprosthetic heart valves
por: Barbarash, Olga, et al.
Publicado: (2015)

Analysis of probable lipotoxic damage and myocardial fibrosis in epicardial obesity
por: Chumakova, Galina, et al.
Publicado: (2021)

Genetic forms and pathophysiology of essential arterial hypertension in minor indigenous peoples of Russia
por: Mulerova, Tatyana, et al.
Publicado: (2020)

Expression of Ceramide-Metabolizing Enzymes in the Heart Adipose Tissue of Cardiovascular Disease Patients
por: Gruzdeva, Olga, et al.
Publicado: (2023)

Prosthetic heart valve selection in women of childbearing age with acquired heart disease: a case report
por: Barbarash, Leonid, et al.
Publicado: (2016)

Characteristics of adipocytokine expression by local fat depots of the heart: Relationship with the main risk factors for cardio-vascular diseases
por: Gruzdeva, Olga V., et al.
Publicado: (2022)

Expression of adipocytokines in heart fat depots depending on the degree of coronary artery atherosclerosis in patients with coronary artery disease
por: Gruzdeva, Olga V., et al.
Publicado: (2021)

Relationship between Epicardial and Coronary Adipose Tissue and the Expression of Adiponectin, Leptin, and Interleukin 6 in Patients with Coronary Artery Disease
por: Gruzdeva, Olga V., et al.
Publicado: (2022)

Effects of Physical Prehabilitation on the Dynamics of the Markers of Endothelial Function in Patients Undergoing Elective Coronary Bypass Surgery
por: Argunova, Yulia, et al.
Publicado: (2022)

Serum neutrophil gelatinase-associated lipocalin has an advantage over serum cystatin C and glomerular filtration rate in prediction of adverse cardiovascular outcome in patients with ST-segment elevation myocardial infarction
por: Barbarash, Olga L., et al.
Publicado: (2017)

Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and Clinical Outcomes at One Year—Hybrid coronary REvascularization Versus Stenting or Surgery (HREVS)
por: Ganyukov, Vladimir, et al.
Publicado: (2020)

Association of Alternative Markers of Carbohydrate Metabolism (Fructosamine and 1,5-Anhydroglucitol) with Perioperative Characteristics and In-Hospital Complications of Coronary Artery Bypass Grafting in Patients with Type 2 Diabetes Mellitus, Prediabetes, and Normoglycemia
por: Sumin, Alexey N., et al.
Publicado: (2023)

The Prognostic Value of Peripheral Artery Diseases in Patients with ST-Segment Elevation Myocardial Infarction
por: Barbarash, Olga L., et al.
Publicado: (2013)

Lipid Testing and Statin Dosing After Acute Myocardial Infarction
por: Wang, William T., et al.
Publicado: (2018)

Increased Serum Parathyroid Hormone, Osteocalcin and Alkaline Phosphatase Are Associated with a Long-Term Adverse Cardiovascular Outcome after Coronary Artery Bypass Graft Surgery
por: Barbarash, Olga, et al.
Publicado: (2019)

Initial statin dose after myocardial infarction and long-term cardiovascular outcomes
por: Kytö, Ville, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hljlp0kijufncah41dfbbcr49a